New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Expert second opinion improves reliability of melanoma diagnoses

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3
Oncology April 07,2024
Expert second opinion improves reliability of melanoma diagnoses

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3
Oncology April 07,2024
Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies
Oncology April 07,2024
Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

Oncology researchers raise ethics concerns posed by patient-facing artificial intelligence

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainReady or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies
Oncology April 07,2024
How oncologists can ethically navigate the 'Right-To-Try' drug law

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs
Oncology April 07,2024
How oncologists can ethically navigate the 'Right-To-Try' drug law

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs
Oncology April 07,2024
Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

by The Wistar InstituteCredit: CC0 Public DomainThe tumor suppressor protein ARID1A controls global transcription in ovarian epithelial cells, according to new research conducted at The Wistar In
Oncology April 07,2024
Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

Unraveling role of tumor suppressor in gene expression and ovarian tumorigenesis

by The Wistar InstituteCredit: CC0 Public DomainThe tumor suppressor protein ARID1A controls global transcription in ovarian epithelial cells, according to new research conducted at The Wistar In
Oncology April 07,2024
Active surveillance feasible for small, low-grade bladder cancer

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F
Oncology April 07,2024
Active surveillance feasible for small, low-grade bladder cancer

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F
Oncology April 07,2024
Active surveillance OK for non-muscle invasive bladder cancer

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U
Oncology April 07,2024
Active surveillance OK for non-muscle invasive bladder cancer

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U
Oncology April 07,2024
Radiation doses from CT scans should be more consistent, say experts

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t
Oncology April 07,2024
Radiation doses from CT scans should be more consistent, say experts

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t
Oncology April 07,2024
Men over 40 with BRCA2 gene fault should get regular PSA screening, experts say

Men over 40 with BRCA2 gene fault should get regular PSA screening, experts say

by Institute of Cancer Research, LondonCredit: CC0 Public DomainGuidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detec
Oncology April 07,2024
Men over 40 with BRCA2 gene fault should get regular PSA screening, experts say

Men over 40 with BRCA2 gene fault should get regular PSA screening, experts say

by Institute of Cancer Research, LondonCredit: CC0 Public DomainGuidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detec
Oncology April 07,2024
Experts establish checklist detailing key consensus reporting items for primary care studies

Experts establish checklist detailing key consensus reporting items for primary care studies

by American Academy of Family PhysiciansCredit: Pixabay/CC0 Public DomainIn an effort to fill the need for primary care–focused guidelines, an international group of top researchers has developed
Public Health & Prevention April 07,2024
Experts establish checklist detailing key consensus reporting items for primary care studies

Experts establish checklist detailing key consensus reporting items for primary care studies

by American Academy of Family PhysiciansCredit: Pixabay/CC0 Public DomainIn an effort to fill the need for primary care–focused guidelines, an international group of top researchers has developed
Public Health & Prevention April 07,2024
Shortage of vital children's cancer drug stirs fear and outrage

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com
Oncology April 07,2024
Shortage of vital children's cancer drug stirs fear and outrage

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com
Oncology April 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com